Previous studies have demonstrated that KRT17 could promote the progression of various malignancies, such as breast cancer,34 cervical carcinoma,35, 36, 37 gastric cancer,38 non–small‐cell lung cancer39 and skin squamous carcinoma.40 This evidence concerns the gene KRT17 and breast carcinoma.